FindTrial
Sign In

dovitinib lactate

DRUG4 trials

Sponsors

Roswell Park Cancer Institute, Heather Wakelee, Academic and Community Cancer Research United

Conditions

Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasGastrinomaGlucagonomaInsulinomaNon-small Cell Lung Cancer (NSCLC), RecurrentNon-small Cell Lung Cancer (NSCLC), Stage IVPancreatic Polypeptide Tumor

Phase 1

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers
CompletedNCT01497392
Roswell Park Cancer InstituteAdenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer +1
Start: 2012-03-29End: 2017-02-07Updated: 2022-07-22
Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)
TerminatedNCT01515969
Heather WakeleeNon-small Cell Lung Cancer (NSCLC), Recurrent, Non-small Cell Lung Cancer (NSCLC), Stage IV
Start: 2012-07-31End: 2014-12-31Updated: 2016-07-12
Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer
WithdrawnNCT02048943
Roswell Park Cancer InstituteDuct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer +2
Start: 2015-03-31Updated: 2015-01-09

Phase 2

Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors
WithdrawnNCT02108782
Academic and Community Cancer Research UnitedGastrinoma, Glucagonoma, Insulinoma +3
Start: 2014-10-31End: 2015-05-31Updated: 2017-07-19

Related Papers

A phase I study to assess the safety, tolerability, and PK of dovitinib (D) in combination with gemcitabine (G) and capecitabine (C) in patients with advanced solid tumors.
Journal of Clinical Oncology2014-05-201 citations